Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours

Technology appraisal guidance
Reference number: TA209
Published: 24 November 2010

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): commentator comments

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): Department of Health response
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): NHS Quality Improvement Scotland response
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): Pfizer response
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): Welsh Assembly Government response

This page was last updated: 13 September 2010